Merck to Present at the 2020 Evercore ISI 3rd Annual HealthCONx Virtual Conference Pharmaceutical Investing
AbbVie to Present at the Evercore ISI Conference and Piper Sandler Healthcare Conference Biotech Investing
Bausch Health Initiates Second Phase 3 Study For NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunction Medical Device Investing
BELLUS Health to Participate in the Evercore ISI 3rd Annual Virtual HealthCONx Conference Biotech Investing
Bristol Myers Squibb Receives European Commission Approval for Opdivo as Second-Line Treatment for Unresectable Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma Biotech Investing
Gilead Sciences to Present at the 3rd Annual Evercore ISI HealthCONx Conference on Wednesday, December 2, 2020 Biotech Investing
Avricore Health's HealthTab Endorsed by Ontario Pharmacists Association for Real-Time COVID-19 Data Reporting in Community Pharmacies Medical Device Investing
Algernon Pharmaceuticals Announces 154 Patients Enrolled in its Multinational Phase 2b/3 Human Study of Ifenprodil for COVID-19 Biotech Investing
Merck Submits Applications for Licensure of V114, the Company's Investigational 15-valent Pneumococcal Conjugate Vaccine, for Use in Adults to the U.S. FDA and European Medicines Agency Pharmaceutical Investing
